Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals
References (21)
- et al.
- et al.
ACC/AHA guide-lines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Taks Force on Practice Guidelines
J Am Coll Cardiol
(2004) - et al.
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integerilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial
J Am Coll Cardiol
(2003) Contemporary management of ST elevation myocardial infarction
Sem Thromb Hemost
(2004)- et al.
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
JAMA
(1997) - et al.
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion
Circulation
(1995) - et al.
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial
Circulation
(1998) - et al.
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
N Engl J Med
(2003) - et al.
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis
Circulation
(2005) - et al.
Abciximab improves microvascular function after rescue PCI: A TIMI 14 substudy
J Am Coll Cardiol
(2000)
Cited by (10)
The effects of fibrinolytic before referring STEMI patients: A systematic review and meta-analysis
2017, IJC Heart and VasculatureCitation Excerpt :A total of 912 studies were identified but only six articles [12–17] met eligible criteria (Fig. 1). Of six included studies, three studies were RCTs [12–14], while the rest were non-RCTs [15–17] with a total of 6523 patients. The characteristics of included studies are shown in Tables 1 and 2.
Part 9: Acute coronary syndromes: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations
2010, ResuscitationCitation Excerpt :Most of these studies have been performed in recent years. Eleven studies supported a facilitated PCI strategy (LOE 1538; LOE 2;464,539–541 LOE 3542–544; LOE 5545–547). Thirty studies show no benefit of PPCI over fibrinolysis (LOE 1405,491,548–554; LOE 2555–560; LOE 5451,561–566,567–574).
Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials
2009, American Journal of Emergency MedicineCitation Excerpt :The study was performed in compliance with the Quality of Reporting of Meta-Analyses (QUORUM) guidelines [11]. Of the 1462 potentially relevant articles initially screened, a total of 7 trial were initially identified [6-7,12-16], and 6 randomized trials [6-7,12-15] were finally included in the meta-analysis (Fig. 1), involving 2684 patients (1403 or 52.3% randomized to combo therapy and 1281 or 47.7% randomized to early Gp IIb-IIIa inhibitors). Characteristics of the included trials are shown in Table 1.
Planning highly specialised services in Catalonia
2008, Medicina ClinicaReperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction. A Comprehensive Review of Contemporary Management Options
2007, Journal of the American College of CardiologyCitation Excerpt :Thus, the use of adjunctive glycoprotein IIb/IIIa inhibition may be important to the success of this approach. Additionally, a recent cost-effectiveness study suggests that a facilitated PCI strategy may have the potential for cost benefits in addition to clinical benefits for patients with STEMI being transferred from community hospitals to undergo PCI (97). Although a facilitated PCI approach remains controversial, and is presently regarded as a class IIb recommendation in the ACC/AHA STEMI management guidelines (2), these data nonetheless suggest that there may be benefit in selected instances where tertiary hospitals and community hospitals can develop an integrated care delivery model.